Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 25 Prostatic Neoplasms 23 Carcinoma, Non-Small-Cell Lung 15 Multiple Myeloma 14 Sarcoma 12 Leukemia, Myeloid, Acute 12 Breast Neoplasms 12 Lymphoma, Non-Hodgkin 10 Glioma 10 Wilms Tumor 9 Colorectal Neoplasms 9 Carcinoma, Hepatocellular 9 Rectal Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Osteosarcoma 8 Neuroblastoma 8 Neoplasm Metastasis 8 Myelodysplastic Syndromes 8 Rhabdomyosarcoma 7 Rhabdoid Tumor 7 Pancreatic Neoplasms 7 Medulloblastoma 7 Hepatoblastoma 7 Neuroectodermal Tumors, Primitive, Peripheral 6 Mouth Neoplasms 6 Melanoma 6 Lymphoma 6 Histiocytosis, Langerhans-Cell 6 Head and Neck Neoplasms 6

Interventions

Endoscopy 13 Endoscopy, Digestive System 12 Radiofrequency Ablation 7 Esomeprazole 7 Biopsy 7 Endoscopic Mucosal Resection 6 Specimen Handling 4 Proflavine 4 Omeprazole 4 Aspirin 4 Gastroscopy 3 YF 476 2 Proton Pump Inhibitors 2 Photochemotherapy 2 Narrow Band Imaging 2 Microscopy, Confocal 2 Metformin 2 Lansoprazole 2 Itraconazole 2 Endoscopes 2 Diagnostic Imaging 2 Dexlansoprazole 2 Cryotherapy 2 Cryosurgery 2 Breath Tests 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 rofecoxib 1 polyphenon E 1 plecanatide 1 omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Barrett Esophagus × X-Rays × Clear all

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡